Glenn Frank Short Atai Life Sciences N.V. (ATAI) insider trading activity
Glenn Frank Short is Chief Scientific Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 42,333 shares of ATAI, which is worth approximately $62,229. The most recent transaction as insider was on Mar 21, 2025, when has been sold 13,161 shares (Common Shares) at a price of $1.35 per share, resulting in proceeds of $17,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
42.3K
n/a
3M change
n/a
12M change
Total Value Held
$62,229
Glenn Frank Short Transaction History
GFS
Glenn Frank Short
Chief Scientific Officer
Berlin, 2M